Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
Founded to enhance late-stage drug development, 9vc focuses on creating and investing in biotech and healthcare companies. The firm employs a proprietary search engine to identify tech-bio partnerships, aiming to reincarnate drugs for patients while delivering value to investors. They concentrate on late-stage clinical development with a specific emphasis on drug development.
9vc invests in late-stage clinical development companies, particularly those involved in drug development. The firm emphasizes asset arbitrage, seeking to capture value in opportunities that others may overlook. Their approach combines technology and expertise to reduce risk and accelerate the realization of value.
Notable investment includes Leona Bio (NASDAQ: LONA), which focuses on developing a phase 2 ready pipeline and is in-licensing a mid-phase 3 asset for treating ESR1-mutant metastatic breast cancer.
Submit through their form at https://9vc.co.
9vc primarily invests in Series C and Growth Equity stages, focusing on late-stage clinical development companies.
The firm targets the biotech and healthcare sectors, specifically companies involved in drug development.
9vc emphasizes asset arbitrage, leveraging technology and expertise to identify and capitalize on overlooked opportunities in drug development.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.